Here are the latest quarterly results of NATCO PHARMA. For more details, see the NATCO PHARMA financial fact sheet and NATCO PHARMA share price. For a sector overview, read our pharmaceuticals sector report.
No. of Mths Qtr. Ending |
3
Dec-22* |
3
Mar-23* |
3
Jun-23* |
3
Sep-23* |
3
Dec-23* |
3
Mar-24* |
3
Jun-24* |
3
Sep-24* |
8-Qtr Chart Click to enlarge |
|
---|---|---|---|---|---|---|---|---|---|---|
Net Sales | Rs m | 4,925 | 8,979 | 11,405 | 10,314 | 7,586 | 10,683 | 13,626 | 13,711 | |
Other income | Rs m | 208 | 290 | 197 | 294 | 370 | 420 | 481 | 638 | |
Turnover | Rs m | 5,133 | 9,269 | 11,602 | 10,608 | 7,956 | 11,103 | 14,107 | 14,349 | |
Expenses | Rs m | 3,866 | 5,588 | 6,125 | 5,734 | 4,905 | 5,710 | 5,578 | 5,668 | |
Gross profit | Rs m | 1,059 | 3,391 | 5,280 | 4,580 | 2,681 | 4,973 | 8,048 | 8,043 | |
Depreciation | Rs m | 415 | 410 | 435 | 436 | 442 | 555 | 441 | 458 | |
Interest | Rs m | 38 | 27 | 42 | 42 | 46 | 62 | 52 | 41 | |
Profit before tax | Rs m | 814 | 3,244 | 5,000 | 4,396 | 2,563 | 4,776 | 8,036 | 8,182 | |
Tax | Rs m | 191 | 486 | 797 | 706 | 436 | 913 | 1,351 | 1,417 | |
Profit after tax | Rs m | 623 | 2,758 | 4,203 | 3,690 | 2,127 | 3,863 | 6,685 | 6,765 | |
Gross profit margin | % | 21.5 | 37.8 | 46.3 | 44.4 | 35.3 | 46.6 | 59.1 | 58.7 | |
Effective tax rate | % | 23.5 | 15.0 | 15.9 | 16.1 | 17.0 | 19.1 | 16.8 | 17.3 | |
Net profit margin | % | 12.6 | 30.7 | 36.9 | 35.8 | 28.0 | 36.2 | 49.1 | 49.3 | |
Diluted EPS | Rs | 3.5 | 15.4 | 23.5 | 20.6 | 11.9 | 21.6 | 37.3 | 37.8 | |
Diluted EPS (TTM) | Rs | 21.7 | 39.9 | 45.5 | 62.9 | 71.3 | 77.5 | 91.4 | 108.5 | |
Subscriber Feature |
After opening the day higher, Indian benchmark indices remained positive as the session progressed and ended the day on firm footing.